• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, February 3, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

A new model to predict survival in colorectal cancer

Bioengineer by Bioengineer
September 3, 2020
in Health
Reading Time: 2 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

This article by Dr. Mohanad Mohammed and colleagues is published in Current Bioinformatics, 2020

IMAGE

Credit: Dr. Mohanad Mohammed et al., Bentham Science Publishers

Colorectal cancer (CRC) is the third most common cancer among women and men in the USA, and recent studies have shown an increasing incidence in less developed regions, including Sub-Saharan Africa (SSA). A team of researchers from South African universities in collaboration with the University of South Carolina-Upstate, have developed method which relies on a hybrid signature (based on patterns in DNA mutation and RNA expression) and assessed its predictive properties for the mutation status and survival of CRC patients.

The research team, led by Mohanad Mohammed at the University of KwaZulu-Natal, South Africa investigated publicly-available microarray and RNASeq data from 54 matched formalin-fixed paraffin embedded (FFPE) samples from the Affymetrix GeneChip and RNASeq platforms. The samples were used to obtain information about differentially expressed genes between mutant and wild-type samples. The researchers then applied bioinformatics techniques which include the use of support-vector machines, artificial neural networks, random forests, k-nearest neighbor, naïve Bayes, negative binomial linear discriminant analysis, and the Poisson linear discriminant analysis algorithms for classification. The Cox proportional hazards model was used for survival analysis.

When compared to the gene list from each of the individual platforms, the researchers noted that the hybrid gene list had the highest accuracy, sensitivity, specificity, and AUC for mutation status, across all the classifiers and is prognostic for survival in patients with CRC. Negative binomial linear discriminant analysis method was the best performer on the RNASeq data while the SVM method was the most suitable classifier for CRC across the two data types. The researchers concluded that nine genes were found to be predictive of survival.

“This signature could be useful in clinical practice, especially for colorectal cancer diagnosis and therapy.”, notes Mohammed. Future studies should determine the effectiveness of integration in cancer survival analysis and the application on unbalanced data, where the classes are of different sizes, as well as on data with multiple classes. The research has been published in the journal, Current Bioinformatics.

###

For more information, please visit: https://www.eurekaselect.com/node/183657/article/colorectal-cancer-classification-and-survival-analysis-based-on-an-integrated-rna-and-dna-molecular-signature

Authors: Mohanad Mohammed1, Henry Mwambi1, and Bernard Omolo2, 3

1School of Mathematics, Statistics and Computer Science, University of KwaZulu-Natal, South Africa
2Division of Mathematics & Computer Science, University of South Carolina-Upstate, USA
3School of Public Health, Faculty of Health Sciences, University of the
Witwatersrand, Johannesburg, South Africa.

Media Contact
Faizan ul Haq
[email protected]

Related Journal Article

http://dx.doi.org/10.2174/1574893615999200711170445

Tags: BioinformaticscancerGeneticsMedicine/HealthMolecular BiologyPharmaceutical SciencesPhysiologyUrogenital System
Share12Tweet8Share2ShareShareShare2

Related Posts

Phase 2 Trial Assesses c-Abl Inhibitor for Early Parkinson’s

February 3, 2026

Using Paid Sick Leave to Prevent Disease Spread

February 3, 2026

Eleven Leading Stroke Researchers Honored for Groundbreaking Contributions to Brain Health and Science

February 3, 2026

Resource Competition Shapes the Human Vaginal Microbiome

February 3, 2026
Please login to join discussion

POPULAR NEWS

  • Enhancing Spiritual Care Education in Nursing Programs

    158 shares
    Share 63 Tweet 40
  • Robotic Ureteral Reconstruction: A Novel Approach

    81 shares
    Share 32 Tweet 20
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    57 shares
    Share 23 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Phase 2 Trial Assesses c-Abl Inhibitor for Early Parkinson’s

Using Paid Sick Leave to Prevent Disease Spread

Photon-Counting CT Surpasses Conventional CT in Lung Cancer Management

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 73 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.